List of works - Kiyomitsu Katsumata

ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.

scientific article published on 9 June 2010

ASP2397 Is a Novel Natural Compound That Exhibits Rapid and Potent Fungicidal Activity against Aspergillus Species through a Specific Transporter

scientific article published on 23 September 2019

Antimicrobial activity of fidaxomicin against Clostridium difficile clinical isolates in Aichi area in Japan.

scientific article published on 17 May 2017

Antiviral efficacy of the helicase-primase inhibitor amenamevir in murine models of severe herpesvirus infection

scientific article published on 24 October 2018

Conferring extracellular matrix affinity enhances local therapeutic efficacy of anti-TNF-α antibody in a murine model of rheumatoid arthritis

scientific article published on 23 December 2019

Effect of ASP2151, a herpesvirus helicase-primase inhibitor, in a guinea pig model of genital herpes ⬇️

scientific article published on August 25, 2011

Enhanced lymph node trafficking of engineered IL-10 suppresses rheumatoid arthritis in murine models

scientific article published on 10 November 2020

Integrative pharmacokinetic-pharmacodynamic modeling and simulation of amenamevir (ASP2151) for treatment of recurrent genital herpes.

scientific article published on 10 June 2016

Pharmacokinetics and Pharmacodynamics of ASP2151, a Helicase-Primase Inhibitor, in a Murine Model of Herpes Simplex Virus Infection ⬇️

scientific article published on December 28, 2012

Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis

scientific article published on 12 October 2020

Publisher Correction: Prolonged residence of an albumin-IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis

scientific article published on 22 October 2020

Susceptibility of Clostridium species isolated in Japan to fidaxomicin and its major metabolite OP-1118.

scientific article published on 17 January 2018

Susceptibility of herpes simplex virus isolated from genital herpes lesions to ASP2151, a novel helicase-primase inhibitor.

scientific article

Synergistic activity of amenamevir (ASP2151) with nucleoside analogs against herpes simplex virus types 1 and 2 and varicella-zoster virus.